125 Cambridgepark Drive Cambridge, MA 02140 +1 877.848.9903
San Francisco – Aug. 19, 2021 – Real Chemistry’s IPM.ai, the leader in uncovering undiagnosed and misdiagnosed patients via machine learning, and Datavant, the leader in helping healthcare and...
Targeted Approach Optimizes Clinical Study Recruitment of Medically-Eligible Patients Affected by Rare Diseases
Leveraging the power of AI and RWD to identify, engage and activate ideal patient populations that could benefit from new therapies and modalities of care.
Subscribe to our newsletter for the latest company updates, industry developments, and media coverage.